Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It… Read more
Market Cap & Net Worth: Laurus Labs Limited (LAURUSLABS)
Laurus Labs Limited (NSE:LAURUSLABS) has a market capitalization of $5.99 Billion (₹518.69 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #3247 globally and #93 in its home market, demonstrating a -6.37% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Laurus Labs Limited's stock price ₹960.80 by its total outstanding shares 539856582 (539.86 Million).
Laurus Labs Limited Market Cap History: 2016 to 2026
Laurus Labs Limited's market capitalization history from 2016 to 2026. Data shows growth from $561.79 Million to $5.99 Billion (29.19% CAGR).
Index Memberships
Laurus Labs Limited is a constituent of 8 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$58.09 Billion | 6.93% | #6 of 20 |
|
NIFTY SMALLCAP 100
NIFSMCP100
|
$104.59 Billion | 3.85% | #2 of 100 |
|
NIFTY 500
NIFTY500
|
$1.33 Trillion | 0.30% | #86 of 500 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$72.50 Billion | 5.55% | #8 of 20 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$535.62 Billion | 0.75% | #30 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.39 Trillion | 0.29% | #87 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$188.43 Billion | 2.14% | #2 of 250 |
|
NIFTY SMALLCAP 50
NISM50
|
$76.26 Billion | 5.28% | #2 of 50 |
Weight: Laurus Labs Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Laurus Labs Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Laurus Labs Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.12x
Laurus Labs Limited's market cap is 0.12 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
1.93x
Laurus Labs Limited's market cap is 1.93 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $561.79 Million | $17.78 Billion | $1.34 Billion | 0.03x | 0.42x |
| 2017 | $635.81 Million | $19.05 Billion | $1.90 Billion | 0.03x | 0.33x |
| 2018 | $445.97 Million | $20.56 Billion | $1.68 Billion | 0.02x | 0.27x |
| 2019 | $433.77 Million | $22.92 Billion | $937.64 Million | 0.02x | 0.46x |
| 2020 | $2.17 Billion | $28.32 Billion | $2.55 Billion | 0.08x | 0.85x |
| 2021 | $3.32 Billion | $48.14 Billion | $9.84 Billion | 0.07x | 0.34x |
| 2022 | $2.32 Billion | $49.36 Billion | $8.28 Billion | 0.05x | 0.28x |
| 2023 | $2.68 Billion | $60.41 Billion | $7.90 Billion | 0.04x | 0.34x |
| 2024 | $3.76 Billion | $50.41 Billion | $1.61 Billion | 0.07x | 2.34x |
| 2025 | $6.91 Billion | $55.54 Billion | $3.58 Billion | 0.12x | 1.93x |
Competitor Companies of LAURUSLABS by Market Capitalization
Companies near Laurus Labs Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Laurus Labs Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Laurus Labs Limited Historical Marketcap From 2016 to 2026
Between 2016 and today, Laurus Labs Limited's market cap moved from $561.79 Million to $ 5.99 Billion, with a yearly change of 29.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹5.99 Billion | -13.29% |
| 2025 | ₹6.91 Billion | +83.84% |
| 2024 | ₹3.76 Billion | +40.34% |
| 2023 | ₹2.68 Billion | +15.19% |
| 2022 | ₹2.32 Billion | -30.10% |
| 2021 | ₹3.32 Billion | +53.28% |
| 2020 | ₹2.17 Billion | +400.06% |
| 2019 | ₹433.77 Million | -2.74% |
| 2018 | ₹445.97 Million | -29.86% |
| 2017 | ₹635.81 Million | +13.18% |
| 2016 | ₹561.79 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Laurus Labs Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.99 Billion USD |
| MoneyControl | $5.99 Billion USD |
| MarketWatch | $5.99 Billion USD |
| marketcap.company | $5.99 Billion USD |
| Reuters | $5.99 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.